Go to the list of all blogs
published in Blogs
Jul 14, 2026
The Baldwin Insurance Group (BWIN) Surges +50.7% on Strategic Review News

The Baldwin Insurance Group (BWIN) Surges +50.7% on Strategic Review News

Key Takeaways

  • The Baldwin Insurance Group (BWIN) surged approximately 50.7% over the last 30 days, driven by reports the company is exploring strategic options including a potential take-private transaction.
  • JPMorgan upgraded BWIN to Overweight from Neutral and raised its price target to $30, reinforcing bullish sentiment around the stock.
  • Multiple analyst firms — including Keefe Bruyette & Woods, TD Cowen, and Morgan Stanley — issued favorable ratings or raised price targets, citing improving fundamentals and attractive valuation.
  • Strong Q1 2026 results, featuring 29% year-over-year revenue growth and rapid synergy capture from the CAC Group acquisition, provided fundamental support for the rally.
  • The stock's quarterly performance reflects a broader recovery from oversold levels, with shares up approximately 13.7% over the last quarter despite earlier weakness.

Company Overview and Market Position

The Baldwin Insurance Group, Inc. — operating under the brand name The Baldwin Group — is an independent insurance distribution firm headquartered in Tampa, Florida. Formerly known as BRP Group, Inc., the company rebranded in May 2024 and trades on the NASDAQ under the ticker BWIN. The firm delivers tailored insurance and risk management solutions across three operating segments: Insurance Advisory Solutions (commercial risk management, employee benefits, and private risk management for businesses and high-net-worth individuals), Underwriting, Capacity & Technology Solutions (including its MGA platform MSI, reinsurance brokerage Juniper Re, and captive management), and Mainstreet Insurance Solutions (personal, commercial, and life and health products distributed through community-based channels). Representing more than three million clients across the United States, Baldwin has built a scalable, technology-enabled platform that combines organic growth with strategic acquisitions — most notably the January 2026 merger with CAC Group, a specialty and middle-market brokerage that significantly expanded the company's capabilities in property and casualty, personal lines, and employee benefits.

Stock Price Performance: Last 30 Days vs. Quarter

BWIN shares delivered a dramatic rally over the last 30 days, climbing approximately 50.7% from a closing price of $18.13 on June 12 to $27.32 as of July 13. The move was punctuated by an explosive single-day surge on June 18, when shares jumped roughly 16.8% on volume exceeding 6.1 million shares — more than three times the daily average — following news that the company had retained advisers to evaluate strategic alternatives including a potential take-private transaction. The rally continued through the end of June and into July, supported by a cascade of analyst upgrades and rising institutional interest. Over the last quarter, BWIN has gained approximately 13.7%, moving from $24.03 in mid-April to the current level. The quarterly trend tells a story of early spring weakness — shares fell as low as $18.13 by mid-June — followed by the sharp late-quarter recovery fueled by strategic speculation and improving sentiment. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

What Drove the 30-Day Surge

The primary catalyst for BWIN's 30-day surge was the June 18 disclosure that the insurance brokerage is exploring strategic options, including a potential take-private deal backed by private equity. This immediately reframed the investment narrative, as insurance brokerages generate recurring, contractual commission revenue and operate with low capital requirements — precisely the profile that attracts private equity buyers who can deploy leverage in ways public markets constrain. JPMorgan analyst Pablo Singzon followed the news on June 22 with an upgrade to Overweight from Neutral, raising the price target to $28 from $25 and describing a take-private as a "credible enough outcome" that could crystallize value. JPMorgan subsequently raised its target again to $30 on July 13. The analyst wave was broad: Morgan Stanley set a $28 target, BMO Capital raised its target to $25, and Keefe Bruyette & Woods lifted its target to $31 with an Outperform rating on July 8. Additionally, Artisan Partners disclosed a new position in early June, voicing confidence in Baldwin's business model and its resilience to AI-driven disruption. The company's Q1 2026 results — $532.2 million in revenue (up 29% year-over-year), adjusted EBITDA of $137.2 million (up 21%), and rapid synergy realization from the CAC Group acquisition — reinforced the fundamental case even as the strategic review captured headlines.

Quarterly Performance Drivers

BWIN's quarterly performance was shaped by two distinct phases. Through April and May, the stock trended lower amid concerns about margin compression, elevated leverage of approximately 4.3x net debt to EBITDA, and modest organic revenue growth of roughly 2% in Q1 2026 — excluding the contribution from newly acquired partnerships. A significant insider sale by major shareholder Elizabeth Krystyn of 130,018 shares at $21.20 on May 7 added to near-term selling pressure. Sentiment began to shift in early June following TD Cowen's reiterated Buy rating and $37 price target, which named BWIN its 2026 small- to mid-cap top pick and highlighted the stock's discounted valuation at 7.2 times 2027 estimated earnings versus a peer average of roughly 14 times. The William Blair Growth Stock Conference presentation on June 3 also provided management an opportunity to articulate the company's growth roadmap. The take-private exploration news in mid-June then served as the decisive turning point, transforming the quarterly performance from negative territory into positive gains and setting the stage for sustained upward momentum into July.

Using Tickeron’s Trending AI Robots for Market Context

In dynamic markets, identifying timely opportunities can be challenging — which is where Tickeron's Trending AI Robots page offers a data-driven resource that I find useful in my own workflow. Tickeron hosts hundreds of AI-powered trading bots that actively trade thousands of tickers across various strategies, timeframes, and market conditions. However, only the top-performing and most relevant bots rise to the Trending section — a curated display designed to highlight strategies that are currently resonating with real-time market dynamics. These bots employ diverse methodologies, from swing trading and trend-following to breakout and pattern-recognition approaches, each with distinct risk and performance profiles. For traders and investors seeking systematic, algorithm-driven insights, exploring the Trending AI Robots page can provide a practical entry point into AI-assisted decision-making. I have used this resource to cross-check momentum signals around names like BWIN when strategic developments emerge. Visit the Trending AI Robots page to discover which strategies are capturing attention right now.

BWIN Stock Forecast Drivers: What Investors Should Watch Next

The most immediate event on BWIN's calendar is the company's second-quarter 2026 earnings report, scheduled for July 30, 2026. Analysts will be closely watching organic revenue growth trends, margin trajectory, progress on the CAC Group integration — including cross-sell execution and further synergy realization — and any updates on the strategic review process. Management previously guided for Q2 revenue of $485 million to $490 million and mid-single-digit organic growth, with acceleration expected in the second half of the year. Beyond earnings, investors should monitor developments around the potential take-private transaction, as any formal offer or termination of the strategic review would likely drive significant price action. Macroeconomic factors — including interest rate expectations, commercial insurance pricing cycles, and credit market conditions — will also influence both Baldwin's operating environment and the feasibility of any leveraged buyout. The company's $250 million share repurchase authorization, with approximately $203 million remaining, represents an additional source of potential demand for shares, though buybacks may be deprioritized if a take-private process advances.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: BWIN

BWIN sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for BWIN moved above the 200-day moving average on July 29, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on BWIN as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BWIN just turned positive on August 03, 2026. Looking at past instances where BWIN's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BWIN advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 214 cases where BWIN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWIN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BWIN broke above its upper Bollinger Band on August 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BWIN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.493) is normal, around the industry mean (6.826). P/E Ratio (0.000) is within average values for comparable stocks, (37.499). BWIN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.750). BWIN's Dividend Yield (0.000) is considerably lower than the industry average of (0.013). P/S Ratio (1.258) is also within normal values, averaging (3.443).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BWIN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 16.36B. The market cap for tickers in the group ranges from 377.24K to 91.63B. MRSH holds the highest valuation in this group at 91.63B. The lowest valued company is TIRX at 377.24K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was 4%. For the same Industry, the average monthly price growth was 35%, and the average quarterly price growth was 45%. HUIZ experienced the highest price growth at 36%, while AIFU experienced the biggest fall at -50%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was -48%. For the same stocks of the Industry, the average monthly volume growth was -95% and the average quarterly volume growth was -15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 70
P/E Growth Rating: 68
Price Growth Rating: 49
SMR Rating: 72
Profit Risk Rating: 82
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
BWIN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry InsuranceBrokersServices

Profile
Details
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.